WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy - 2000 - 2003
(2000; 81 pages) [French] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentAbbreviations, Acronyms & WHO Regions
View the documentHighlights - WHO Medicines Strategy: 2000 - 2003
Open this folder and view contents1. The Impact of Essential Drugs
Open this folder and view contents2. Strategic Directions
View the document3. Core Functions Improving Health Through Knowledge, Advocacy and Partnership
Open this folder and view contents4. Country Work - Why and How?
Open this folder and view contents5. Framework for Action: Objectives and Expected Outcomes for 2000 - 2003
Close this folder6. Monitoring Progress
View the document6.1 Monitoring, evaluation and indicators
View the document6.2 Country progress indicators for the WHO Medicines Strategy
View the document6.3 Indicator values for the WHO Medicines Strategy
View the document6.4 Improving the monitoring/evaluation process and tools
View the documentReferences and Notes
 

6. Monitoring Progress

“Monitoring is an integral part of day-to-day management in successful drug programs. Systematic monitoring, based on program objectives and linked to specific activities, is essential for improving program performance and achieving long-term program goals.”

Management Sciences for Health/World Health Organization, 1997. 50

to previous section to next section
 

Last updated: April 24, 2012